UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2834) 2834
Book Chapter (73) 73
Newspaper Article (38) 38
Magazine Article (5) 5
Transcript (4) 4
Trade Publication Article (2) 2
Dissertation (1) 1
Newsletter (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (2259) 2259
life sciences & biomedicine (2170) 2170
humans (1729) 1729
male (1286) 1286
dopamine (1247) 1247
animals (1192) 1192
neurosciences & neurology (1057) 1057
neurosciences (998) 998
female (825) 825
pharmacology & pharmacy (744) 744
psychiatry (672) 672
rats (547) 547
adult (527) 527
dopamine uptake inhibitors - adverse effects (484) 484
dopamine - metabolism (478) 478
parkinson's disease (419) 419
clinical neurology (388) 388
middle aged (386) 386
cocaine (375) 375
serotonin (355) 355
dopamine uptake inhibitors - therapeutic use (336) 336
neurology (302) 302
dose-response relationship, drug (288) 288
rats, sprague-dawley (285) 285
dopamine uptake inhibitors - pharmacology (273) 273
treatment outcome (269) 269
drug therapy (252) 252
cocaine - adverse effects (249) 249
research (249) 249
bupropion - therapeutic use (241) 241
dopamine uptake inhibitors - administration & dosage (238) 238
disease models, animal (236) 236
mice (236) 236
rodents (218) 218
parkinson disease - drug therapy (207) 207
brain (202) 202
time factors (200) 200
aged (193) 193
brain - drug effects (192) 192
dopamine receptors (192) 192
health aspects (187) 187
antidepressants (186) 186
adolescent (179) 179
analysis (177) 177
brain - metabolism (176) 176
bupropion (176) 176
care and treatment (170) 170
motor activity - drug effects (167) 167
movement disorders (167) 167
pharmacology/toxicology (165) 165
biochemistry & molecular biology (164) 164
double-blind method (163) 163
cocaine - pharmacology (162) 162
drug abuse (162) 162
neurons (162) 162
pharmacology (162) 162
mental disorders (161) 161
medicine & public health (160) 160
bupropion - adverse effects (159) 159
parkinsons disease (159) 159
biomedicine (156) 156
physiological aspects (153) 153
risk factors (153) 153
pharmacotherapy (152) 152
smoking cessation (152) 152
abridged index medicus (151) 151
neurodegenerative diseases (150) 150
schizophrenia (149) 149
smoking cessation - methods (148) 148
drugs (147) 147
serotonin - metabolism (146) 146
studies (144) 144
norepinephrine (142) 142
serotonin uptake inhibitors - therapeutic use (142) 142
review (141) 141
serotonin uptake inhibitors - adverse effects (141) 141
nervous system (139) 139
phenols (139) 139
clinical trials (138) 138
behavior, animal - drug effects (135) 135
psychopharmacology (134) 134
substance abuse (133) 133
neurotransmitters (131) 131
toxicology (129) 129
cocaine - administration & dosage (128) 128
medicine (127) 127
corpus striatum - metabolism (126) 126
rats, wistar (125) 125
dopamine transporter (124) 124
drug dosages (124) 124
addiction (114) 114
internal medicine (114) 114
neurons - drug effects (114) 114
pregnancy (114) 114
corpus striatum - drug effects (113) 113
self administration (113) 113
analysis of variance (112) 112
general & internal medicine (112) 112
parkinson’s disease (112) 112
psychology (112) 112
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2911) 2911
French (16) 16
Spanish (12) 12
German (8) 8
Japanese (7) 7
Dutch (6) 6
Polish (6) 6
Norwegian (3) 3
Portuguese (3) 3
Swedish (3) 3
Chinese (2) 2
Hungarian (2) 2
Italian (1) 1
Russian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
The New England journal of medicine, ISSN 1533-4406, 03/2006, Volume 354, Issue 12, pp. 1243 - 1252
Journal Article
Pharmacology & therapeutics (Oxford), ISSN 0163-7258, 05/2006, Volume 110, Issue 2, pp. 135 - 370
.... Currently available drugs display limited efficacy and a pronounced delay to onset of action, and all provoke distressing side effects... 
Antidepressant | Multi-target | SSRI | Mood | Network theory | Depression | Co-morbidity | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Depressive Disorder, Major - etiology | Cyclohexanols - adverse effects | Dopamine Uptake Inhibitors - adverse effects | Depressive Disorder, Major - metabolism | Humans | Dopamine Uptake Inhibitors - therapeutic use | Nerve Net - drug effects | Drug Delivery Systems | Brain - metabolism | Drug Design | Neurons - metabolism | Drug Therapy, Combination | Neurons - drug effects | Dopamine - metabolism | Morpholines - adverse effects | Morpholines - therapeutic use | Bupropion - therapeutic use | Depressive Disorder, Major - drug therapy | Adrenergic Uptake Inhibitors - adverse effects | Antidepressive Agents - classification | Adrenergic Uptake Inhibitors - therapeutic use | Serotonin Uptake Inhibitors - therapeutic use | Serotonin Uptake Inhibitors - adverse effects | Clinical Trials as Topic | Antidepressive Agents - therapeutic use | Brain - drug effects | Venlafaxine Hydrochloride | Animals | Norepinephrine - metabolism | Serotonin - metabolism | Nerve Net - metabolism | Cyclohexanols - therapeutic use | Bupropion - pharmacology | Antidepressive Agents - adverse effects | Nitrogen oxide | Drugs | Neuropeptide Y | Care and treatment | Monoamine oxidase | Corticosteroids | Neurons | Glycogen | Depression, Mental | Development and progression | Serotonin uptake inhibitors | Peptide hormones | Methyl aspartate | Synthesis | Workplace multiculturalism | GABA | Drug therapy, Combination | Health aspects | Noradrenaline | Index Medicus
Journal Article